Preparation and characterization of dexamethasone-immobilized chitosan scaffold

Journal of Bioscience and Bioengineering

Volumn 113, Issue 5, 2012, Pages 654-660

  Chiang, Zu Chian ^a   Yu, Shu Huei ^b   Chao, An Chong ^a   Dong, Guo Chung ^a,c  

^a NATIONAL UNITED UNIVERSITY   (Taiwan)

^b VANUNG UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

AD MSCs; Cell images; Chitosan; Dexamethasone; Immobilization

Indexed keywords

ACTIVITY ASSAYS; AD-MSCS; AMINO GROUP; ANALYSIS METHOD; ATR-FT-IR SPECTROSCOPY; BONE TISSUE ENGINEERING; CARBONYL GROUPS; CELL IMAGES; CHITOSAN FILM; CHITOSAN SCAFFOLD; DEXAMETHASONES; INTEGRATED AREAS; OSTEOGENIC DIFFERENTIATION; WEIGHTING METHODS;

CHITOSAN; FLOWCHARTING; FOURIER TRANSFORM INFRARED SPECTROSCOPY; RADIOACTIVE WASTE VITRIFICATION; SCAFFOLDS (BIOLOGY);

CELL IMMOBILIZATION;

ALCOHOL; ALKALINE PHOSPHATASE; AMINO ACID; CARBONYL DERIVATIVE; CHITOSAN; DEXAMETHASONE;

ARTICLE; ATTENUATED TOTAL REFLECTANCE FOURIER TRANSFORM INFRARED SPECTROSCOPY; CELL DIFFERENTIATION; CELL LINEAGE; CHEMICAL REACTION; CONTROLLED STUDY; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMOBILIZATION; INFRARED SPECTROSCOPY; OSTEOBLAST;

BONE AND BONES; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; CHITOSAN; DEXAMETHASONE; HUMANS; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84859917885     PISSN: 13891723     EISSN: 13474421     Source Type: Journal    
DOI: 10.1016/j.jbiosc.2012.01.002     Document Type: Article

References (36)

1. Sachlos E., Czernuszka J.T. Making tissue engineering scaffolds work. Eur. Cell. Mater. 2003, 5:29-40.
2. Puleoa D.A., Kisslinga R.A., Sheub M.S. A technique to immobilize bioactive proteins, including bone morphogenetic protein-4 (BMP-4), on titanium alloy. Biomaterials 2002, 23:2079-2087.
3. Osathanon T., Giachelli C.M., Somerman M.J. Immobilization of alkaline phosphatase on microporous nanofibrous fibrin scaffolds for bone tissue engineering. Biomaterials 2009, 30:4513-4521.
4. Shi Z., Neoh K.G., Kang E.T., Poh C.K., Wang W. Surface functionalization of titanium with carboxymethyl chitosan and immobilized bone morphogenetic protein-2 for enhanced osseointegration. Biomacromolecules 2009, 10:1603-1611.
5. Schugens C.H., Grandfils C.H., Jerome R., Teyssie P., Delree P., Martin D., Malgrange B., Moonen G. Preparation of a macro-porous biodegradable polylactide implant for neuronal transplantation. J. Biomed. Mater. Res. 1995, 29:1349-1362.
6. Ho M.H., Wang D.M., Hsieh H.J., Liu H.C., Hsien T.Y., Lai J.Y., Hou L.T. Preparation and characterization of RGD-immobilized chitosan scaffolds. Biomaterials 2005, 26:3197-3206.
7. Hu Y., Winn S.R., Krajbicj I., Hollinger J.O. Porous polymer scaffolds surface-modified with arginine-glycine-aspartic acid enhance bone cell attachment and differentiation in vitro. J. Biomed. Mater. Res. 2003, 64A:583-590.
8. Albelda S.M., Buck C.A. Integrins and other cell adhesion molecules. FASEB J. 1990, 4:2868-2880.
9. Massia S.P., Hubbell J.A. Covalent surface immobilization of Arg-Gly-Asp and Try-Ile-Gly-Ser-Arg containing peptides to obtain well defined cell-adhesive substrates. Anal. Biochem. 1990, 187:292-301.
10. Shin H., Temenoff J.S., Bowden G.C., Zygourakis K., Farach-Carson M.C., Yaszemski M.J., Mikos A.G. Osteogenic differentiation of rat bone marrow stromal cells cultured on Arg-Gly-Asp modified hydrogels without dexamethasone and β-glycerolphosphate. Biomaterials 2005, 26:3645-3654.
11. Chung T.W., Lu Y.F., Wang S.S., Lin Y.S., Chu S.H. Growth of human endothelial cells on photochemically grafted Gly-Arg-Gly-Asp (GRGD) chitosans. Biomaterials 2002, 23:4803-4809.
12. Burdick J.A., Anseth K.S. Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. Biomaterials 2002, 23:4315-4323.
13. Kim S.E., Song S.H., Yun Y.P., Choi B.J., Kwon I.K., Bae M.S., Moon H.J., Kwon Y.D. The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function. Biomaterials 2011, 32:366-373.
14. Wildemann B., Lange K., Strobel C., Fassbender M., Willie B., Schmidmaier G. Local BMP-2 application can rescue the delayed osteotomy healing in a rat model. Injury 2011, 42:746-752.
15. Schuessele A., Mayr H., Tessmar J., Goepferich A. Enhanced bone morphogenetic protein-2 performance on hydroxyapatite ceramic surfaces. J. Biomed. Mater. Res. 2009, 90A:959-971.
16. Yin Y.J., Ye F., Cui J.F., Zhang F.J., Li X.L., Yao K.D. Preparation and characterization of macroporous chitosan-gelatin beta-tricalcium phosphate composite scaffolds for bone tissue engineering. J. Biomed. Mater. Res. 2003, 67:844-855.
17. Hu Q.L., Li B.Q., Wang M., Shen J.C. Preparation and characterization of biodegradable chitosan/hydroxyapatite nanocomposite rods viain situ hybridization: a potential material as internal fixation of bone fracture. Biomaterials 2004, 25:779-785.
18. Li Z., Ramay H.R., Hauch K.D., Xiao D., Zhang M. Chitosan-alginate hybrid scaffolds for bone tissue engineering. Biomaterials 2005, 26:3919-3928.
19. Jiang T., Abdel-Fattah W.I., Laurencin C.T. In vitro evaluation of chitosan/poly(lactic acid-glycolic acid) sintered microsphere scaffolds for bone tissue engineering. Biomaterials 2006, 27:4894-4903.
20. Thein-Han W.W., Misra R.D.K. Biomimetic chitosan-nanohydroxyapatite composite scaffolds for bone tissue engineering. Acta Biomater. 2009, 5:1182-1197.
21. Chiang Z.C., Li H.Y., Chao A.C., Su Y.R. Characterization of the morphology and hydrophilicity of chitosan/caffeic acid hybrid scaffolds. J. Polym. Res. 2011, 18:2205-2212.
22. Tsai W.B., Chen Y.R., Liu H.L., Lai J.Y. Fabrication of UV-crosslinked chitosan scaffolds with conjugation of RGD peptides for bone tissue engineering. Carbohydr. Polym. 2011, 85:129-137.
23. Gomes M., Azevedo H., Malafaya P.B., Silva S.S., Oliveira J.M., Silva G.A., Sousa R., Mano J.F., Reis R.L. Natural polymers in tissue engineering applications, pp. 145-192. Tissue engineering 2008, Academic Press series in biomedical engineering. Academic Press, London, Burlington, San Diego. C. van Blitterswijk, P. Thomsen, J. Hubbell, R. Cancedda, J.D. de Bruijn, A. Lindahl, J. Sohier, D.F. Williams (Eds.).
24. Jayakumar R., Prabaharan M., Reis R.L., Mano J.F. Graft copolymerized chitosan-present status and applications. Carbohydr. Polym. 2005, 62:142-158.
25. Joshi J.M., Sinha V.K. Ceric ammonium nitrate induced grafting of polyacrylamide onto carboxymethyl chitosan. Carbohydr. Polym. 2007, 67:427-435.
26. Mu Q., Fang Y. Preparation of thermosensitive chitosan with poly(N-isopropylacrylamide) side at hydroxyl group via O-maleoyl-N-phthaloyl chitosan (MPCS). Carbohydr. Polym. 2008, 72:308-314.
27. Lim T.Y., Wang W., Shi Z., Poh C.K., Neoh K.G. Human bone marrow-derived mesenchymal stem cells and osteoblast differentiation on titanium with surface-grafted chitosan and immobilized bone morphogenetic protein-2. J. Mater. Sci. 2009, 20:1-10.
28. Masuko T., Iwasaki N., Yamane S., Funakoshi T., Majima T., Minami A., Ohsuga N., Ohta T., Nishimura S.I. Chitosan-RGDSGGC conjugate as a scaffold material for musculoskeletal tissue engineering. Biomaterials 2005, 26:5339-5347.
29. Karakecili A.G., Demirtas T.T., Satriano C., Gümüsderelioglu M., Marletta G. Evaluation of L929 fibroblast attachment and proliferation on Arg-Gly-Asp-Ser (RGDS)-immobilized chitosan in serum-containing/serum-free cultures. J. Biosci. Bioeng. 2007, 104:69-77.
30. Cheng S.L., Yang J.W., Rifas L., Zhang S.F., Avioli L.V. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 1994, 134:277-286.
31. Beresford J.N., Joyner C.J., Devlin C., Triffitt J.T. The effects of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro. Arch. Oral Biol. 1994, 39:941-947.
32. Jørgensen N.R., Henriksen Z., Sørensen O.H., Civitelli R. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids 2004, 69:219-226.
33. Pri-Chen S., Pitaru S., Lokiec F., Savion N. Basic fibroblast growth factor enhances the growth and expression of the osteogenic phenotype of dexamethasone-treated human bone marrow-derived bone-like cells in culture. Bone 1998, 23:111-117.
34. Seib F.P., Franke M., Jing D., Werner C., Bornhauser M. Endogenous bone morphogenetic proteins in human bone marrow-derived multipotent mesenchymal stromal cells. Eur. J. Cell Biol. 2009, 88:257-271.
35. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J.M., Fujisawa-Sehara A., Suda T. Bone morphogenic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 1994, 127:1755-1766.
36. Yamanouchi K., Gotoh Y., Nagayamak M. Dexamethasone enhances differentiation of human osteoblastic cells in vitro. J. Bone Miner. Metab. 1997, 15:23-29.